Ian L. Linde

1.1k citations
11 papers · 458 indexed · 1 hit paper · h-index 9
Topics
Immunotherapy and Immune Responses (7 papers)CAR-T cell therapy research (4 papers)Virus-based gene therapy research (3 papers)

In The Last Decade

Ian L. Linde

11 papers receiving 451 citations

Hit Papers

Neutrophil-activating therapy for the treatment of cancer20232026202420252023255075100

Peers

Ian L. Linde
Comparison fields: 5 of 58
  • Immunology 299
  • Oncology 220
  • Molecular Biology 160
  • Biomedical Engineering 57
  • Radiology, Nuclear Medicine and Imaging 40
Replace Heinke Conrad with:
Heinke Conrad Germany
Frederike A. Hartl Germany
Thérèse Liechtenstein United Kingdom
J H S Diepstra Netherlands
Cathrine Lund Lorentzen Denmark
Esther D. Kers‐Rebel Netherlands
Giulia Chiaruttini United Kingdom
Ryan Bjordahl United States
Ian L. Linde relative to Heinke Conrad Germany Heinke Conrad's profile →
Citations per field
00.5×10×15×18.6×
Heinke Conrad · 1×
Citations per year

Countries citing papers authored by Ian L. Linde

Since Specialization
Citations

This map shows the geographic impact of Ian L. Linde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian L. Linde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian L. Linde more than expected).

Fields of papers citing papers by Ian L. Linde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian L. Linde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian L. Linde. The network helps show where Ian L. Linde may publish in the future.

Co-authorship network of co-authors of Ian L. Linde

This figure shows the co-authorship network connecting the top 25 collaborators of Ian L. Linde. A scholar is included among the top collaborators of Ian L. Linde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian L. Linde. Ian L. Linde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 29
2 33
3
Neutrophil-activating therapy for the treatment of cancerbreakdown →
117
4 25
5 32
6 1
7 20
8 13
9 6
10 170
11 12

About Ian L. Linde

Ian L. Linde is a scholar working on Immunology, Oncology and Biotechnology, having authored 11 papers that have together received 458 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Immunology (299 citations), Oncology (220 citations) and Molecular Biology (160 citations). Ian L. Linde has collaborated with scholars based in United States, South Africa and India. Frequent co-authors include Edgar G. Engleman, Tyler R. Prestwood, Yaron Carmi, Bryan M. Burt, Matthew H. Spitzer, Nupur Bhattacharya, Matthew G. Davidson, Nicola Perlman, Ganesh V. Pusapati and Justin A. Kenkel. Their work appears in journals such as Nature, Cancer Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026